3827 results

PCR TV: Valve selection considerations for the Heart Team

11 Oct 2021

Which valve for which patient? The question is no longer just whether to choose a balloon-expandable or a self-expanding valve: low-risk indications, increasing number of TAVI procedures, and growing complexity of patients are leading the TAVI community to become more prescriptive and to take time to...

Partner-funded invitation for #GulfPCR

Thanks to the support of our valued Industry Partners, healthcare professionals can benefit from a 100% funded invitation* to attend GulfPCR-GIM 2021 in Dubai.

Bifurcation Lesions Sessions

17 Feb 2022

Watch the recordings of these sessions on PCR in patients with complex lesions ACS and HBR and complex Bifurcation PCI: What to avoid?

PCR-TV: reducing permanent pacemaker implantation post-TAVR: tips & tricks

15 Sep 2021

In this video, Kuljit Singh, Anthony Camuglia and Ganesh Manoharan discuss both the Cusp overlap technique as a way to reduce permanent pacemaker implantation post transcatheter aortic valve replacement (TAVR) and the frame alignment technique to optimise TAV implantation.

TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review

09 Nov 2021

 

The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Author

Alessandro Sticchi

Author

Jonathan Curio

EAPCI Physicians' exam - get your Interventional Cardiology Certification!

01 Nov 2021

Assess your competence in knowledge, skills and attitudes in interventional cardiology by applying for the #EAPCI Certification exam !

Partners List for Tokyo Valves 2020

Discover the partners, conference and media partners that were taking part in the 2020 edition of PCR Tokyo Valves.

PCR Companions - View the best snapshots of your companions!

29 Oct 2019

Get an insight of how companions enjoy fruitful networking at PCR Courses across the globe

EuroPCR 2022 – Local Pods

Local Pods are a great way to follow #EuroPCR with a group of local peers who are not in a position to travel to France. They also allow the programme to be adapted to meet regional educational needs.

EBC MAIN trial results – what is new and what will change in left main stenting?

18 May 2021

The European Bifurcation Club Left Main (EBC MAIN) trial addressed the issue of provisional single stent versus upfront double stenting in 467 patients with true bifurcation distal left main disease. 

So far, only one other randomized trial, DKCRUSH-V (n=482), has addressed the same research question, showing better...

A new meta-analysis supports elective revascularization and medical therapy for reducing cardiac death

18 May 2021

The ISCHEMIA trial found no significant difference between an invasive vs. a conservative strategy in patients with chronic coronary syndromes and moderate to severe ischemia at a mean of 3.2 years. However, the cumulative difference in the estimates of cardiac death between the invasive and conservative...

Discover the new Evolut­™ PRO+ TAVI System

17 Jun 2021

New data from Optimize PRO interim analysis

From a design built on a proven platform1, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.

Distal radial approach to reaccess and recanalize the occluded radial artery

30 Apr 2021

A 56-year-old man was re-admitted with chest pain. He had been hospitalized 2 weeks before because of MI, was suffering from metastatic carcinoma with recurrent PTE, and was on long-term subcutaneous heparin...

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

One-year results from the FUTURE-II trial

18 May 2021

A decade already passed from the first use of bioresorbable vascular scaffold in percutaneous coronary interventions. The first studies - by using surrogate endpoints - showed some superiority of BRS vs. metallic drug-eluting stent in terms of the so-called vascular restoration therapy with recovery of vasomotion...

We CARE: a joint initiative by PCR and Stent – Save a Life!

07 May 2021

Discover all about the advocacy programme that aims to restore patients’ confidence that seeking timely medical care for heart disease is both necessary and safe.

BIOSOLVE-IV full-cohort two-year data confirm excellent safety and efficacy profile of Magmaris resorbable magnesium scaffold

23 Sep 2022

Cool AMI EU pivotal trial- final results after trial discontinuation following ad interim analysis

18 May 2021

Results of the interim analyses performed after 12 months in the first 111 patients enrolled in phase II Cool AMI trial evaluating safety and effectiveness of systemic therapeutic hypothermia as an adjunctive therapy in anterior STEMI undergoing PCI as compared to PCI only. Analyses showed significant...

Real-world outcomes with the PASCAL Platform in TR

03 Dec 2021

The PASCAL platform, comprising the PASCAL and PASCAL Ace implants, received its CE mark for TR in May 2020 and has been shown to be an effective and safe treatment option for patients with TR.3,4,6 Professor Jörg Hausleiter and Dr Mirjam Wild now describe their single-centre experience...

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry

17 Sep 2022

Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Author

Mirvat Alasnag